Infectious Disease

Real-Time Data Solutions

Infectious disease studies frequently call for urgent and accelerated trial timelines, and requirements for patient participation and high-quality data are often more stringent. The declaration of a new virus or pandemic requires rapid response to develop and implement highly time-sensitive clinical trials.

Infectious disease trials require careful patient safety monitoring and close collaboration between study teams and regulatory authorities. Identifying and enrolling eligible patients is challenging. Target populations are at high risk for infection, often with compromised immune systems or underlying chronic conditions. Investigating treatments can have significant risks or side effects, be controversial, or raise ethical concerns.

Infectious disease trials require careful patient safety monitoring and close collaboration between study teams and regulatory authorities. Investigating treatments can present significant risks or side effects, be controversial, or raise ethical concerns.

Infectious disease clinical trials

Uninterrupted Real-Time Data Continuity​

As COVID-19 spread worldwide, researchers raced to develop effective diagnostics, vaccines, and treatments. Traditional decade-long timelines were reduced to under twelve months, and the FDA granted Emergency Use Authorization in record time.

Drug development during COVID-19 demonstrated the power of clinical trial digital technology. Powering research to stay on track during times of extreme disruption, mobile technology, telehealth, and remote monitoring enable patients to participate in research projects from anywhere.

Access to real-time data captured with Direct Data Capture (DDC) technology, electronic Patient-Reported Outcomes (ePRO) and electronic Clinical Outcome Assessments (eCOA) provide infectious study teams with real-time data collection, analysis, and quality required for immediate insights and interim analysis reporting.

eSource Solutions for Infectious Disease Trials

In evolving infectious disease situations, proven digital technology solutions guarantee your ability to respond quickly to individual or epidemiologic developments.

CASE STUDY

See how real-time, remote data collection enabled rapid, agile deployment of an infectious disease trial.

Scroll to Top